The Future of HIV-1 Therapeutics Resistance Is Futile? /
This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2015.
|
Σειρά: | Current Topics in Microbiology and Immunology,
389 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- HIV Therapy Looking Towards the Future
- Computational challenges of structure-based approaches applied to HIV
- Nucleocapsid Protein: A Desirable Target For Future Therapies Against HIV-1
- HIV-1 integrase multimerization as a therapeutic target
- Targeting HIV transcription: The quest for a functional cure
- Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder
- HIV-1 Gag: An Emerging Target for Antiretroviral Therapy
- The Triple Threat of HIV-1 Protease Inhibitors
- Illustrations of the HIV Life Cycle.